Question 1

What is Plozasiran?

Accepted Answer

Plozasiran is a Other.

Question 2

How often does Plozasiran appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Plozasiran first tracked by Ergen?

Accepted Answer

First tracked on May 26, 2026.

Question 4

When was Plozasiran last mentioned in news?

Accepted Answer

Last active on May 26, 2026.

Question 5

What is Plozasiran's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Plozasiran in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Plozasiran?

Accepted Answer

Arrowhead Presents Positive Plozasiran Data (May 26, 2026, 6 articles).

Question 8

How did the "Arrowhead Presents Positive Plozasiran Data" event impact Plozasiran?

Accepted Answer

Plozasiran, an siRNA medicine, showed positive clinical data for use in patients with renal or hepatic impairment without dose adjustment and sustained triglyceride lowering during pregnancy, expanding its potential patient population and market.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.